Analyst Ratings for Infinity Pharmaceutical (INFI) [Neutrals]

INFI Rating Summary

INFI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on INFI
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $1.56 (-3%) * Over Last 12-Mos
Rating Score: 3.9 / 10   Percentile Rank: 39%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/15/2016 JMP Securities Downgrade Market Perform
(Market Outperform)
N/A
(N/A)
1.36 1.61 18.38% Details
6/15/2016 Wells Fargo Downgrade Market Perform
(Outperform)
N/A
(N/A)
1.36 1.61 18.38% Details
Like INFI Ratings? Also take a look at ABBV, EGRX, HCP, IMMU

INFI Ratings News